Novozymes A/S (NVZMF) Stock Price, News & Analysis

Company Overview

Novozymes A/S was a Danish biotechnology company specializing in enzymes, microorganisms and other biological solutions for industrial and consumer applications. Its technologies were designed to help customers improve production efficiency, reduce resource consumption and develop more sustainable products.

The company supplied biological solutions for industries including food and beverages, agriculture, household care, bioenergy, textiles and other manufacturing activities. Its offerings included enzymes used in baking, brewing, animal feed, detergents, biofuels and industrial processing, as well as microbial products intended to support agricultural productivity and environmental performance.

Novozymes was established in 2000 after being separated from Novo Nordisk and served customers internationally through research, development and commercial operations across multiple regions. In 2024, Novozymes combined with Chr. Hansen Holding A/S, creating Novonesis, a biosolutions company focused on enzymes, microorganisms and related biological technologies. Novozymes A/S is therefore primarily a historical company name associated with the business now operating under the Novonesis name.

Key Stats

• Today's Range: $66.03 to $66.03
• 50-Day Range: $61.10 to $71.12
• 52-Week Range: $52.10 to $72.98
• Volume: 150 shs
• Average Volume: 1,464 shs
• Market Capitalization: N/A
• P/E Ratio: 8.23
• Dividend Yield: 2.73%
• Price Target: N/A
• Consensus Rating: N/A

Novozymes A/S Stock Analysis - MarketRank™

Novozymes A/S scored higher than 24% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Novozymes A/S.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Novozymes A/S is 8.23, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.00.

Price to Earnings Ratio vs. Sector

The P/E ratio of Novozymes A/S is 8.23, which means that it is trading at a less expensive P/E ratio than the Materials sector average P/E ratio of about 26.09.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Novozymes A/S has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.

Change versus previous month

Short interest in Novozymes A/S has recently decreased by 20.07%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Novozymes A/S has a dividend yield of 0.72%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Novozymes A/S does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Novozymes A/S is 22.44%. This payout ratio is at a healthy, sustainable level, below 75%.

News and Social Media

• Score: 3.0 / 5
• News Sentiment: N/A

News Sentiment

Novozymes A/S has a news sentiment score of 0.75. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Materials companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Novozymes A/S this week, compared to 0 articles on an average week.

Company Ownership

• Score: 0.2 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Novozymes A/S insiders have not sold or bought any company stock.

Percentage Held by Institutions

20.41% of the stock of Novozymes A/S is held by institutions.

Company Calendar

• Last Earnings: 4/20/2016
• Today: 9/23/2026
• Next Earnings (Estimated): 11/05/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Materials
• Industry: Chemicals
• Sub-Industry: Specialty Chemicals
• Current Symbol: OTCMKTS:NVZMF
• CIK: 1131345
• Web: www.novonesis.com
• Phone: (454) 446-0000
• Fax: N/A
• Employees: 11,641
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: 8.23
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A